Multicenter Postmarket Surveillance Registry Evaluating Performance and Long Term Safety of the Presillion Stent
NCT ID: NCT00968019
Last Updated: 2013-03-13
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
318 participants
OBSERVATIONAL
2009-04-30
2011-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prospective Registry of ihtDEStiny® Coronary Stent in Regular PCI Practice
NCT04899141
Long Term Safety Profile of the PRO-Kinetic ENERGY Coronary Stent System in Daily Clinical Practice
NCT01056120
Intra-patient Study With Polymer Free Drug Eluting Stent Versus Abluminal Biodegradable Polymer Drug Eluting Stent With Early OCT (Optical Coherence Tomography) Follow up
NCT02785237
Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease
NCT05846893
Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth
NCT00349895
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Data will be collected on 400 patients (from 14 hospitals in Spain and Portugal) treated with the Presillion stent in up to 2 de novo native coronary artery lesions
Study design: multicenter, prospective, observational
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Presillion stent
Patients treated with the Presillion stent in up to two de novo coronary artery lesions
Presillion stent
Centers will use commercially available Presillion Stents as recommended according to the Instruction For Use (IFU).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Presillion stent
Centers will use commercially available Presillion Stents as recommended according to the Instruction For Use (IFU).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Johnson and Johnson, S.A.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Angel Cequier, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Hospital Universitario de Bellvitge
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Garcia Da Orta
Almada, , Portugal
Hospital de Santa Cruz
Lisbon, , Portugal
Hospital Sao Joao
Porto, , Portugal
Centro Hospitalar Vila Real
Vila Real, , Portugal
Complejo Hospitalario Universitario de Albacete
Albacete, Albacete, Spain
Hospital Germans Trias I Pujol
Badalona, Barcelona, Spain
Centro Medico Teknon
Barcelona, Barcelona, Spain
Hospital de La Santa Creu I Sant Pau
Barcelona, Barcelona, Spain
Hospital Universitario de Bellvitge
L'Hospitalet de Llobregat, Barcelona, Spain
Capio Hospital General de Cataluña
Sant Cugat del Vallès, Barcelona, Spain
Hospital Universitario Marques de Valdecilla
Santander, Cantabria, Spain
Hospital Universitario Arnau de Vilanova
Lleida, Lerida, Spain
Hospital Universitario Central de Asturias
Oviedo, Principality of Asturias, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
08-CR-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.